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Background: The biological processes involved in the development of gastric mucosal atrophy and
intestinal metaplasia are still incompletely understood. Reports testing the hypothesis that apoptosis
leads to atrophy have yielded conflicting results. The availability of new antibodies for the detection of
apoptotic cells in tissue sections has facilitated the analysis of the role of apoptosis in the
gastritis–atrophy–intestinal metaplasia sequence.
Methods: Archival material from 40 gastric resection specimens with normal mucosa (n = 5), chronic
active gastritis (n = 17), or intestinal metaplasia (n = 18) was studied. Immunohistochemistry was per-
formed using antibodies directed against cleaved cytokeratin 18 and active caspase 3. Slides were
scored on a 0–3 scale for the presence of apoptotic cells.
Results: Normal gastric mucosa contained low numbers of apoptotic cells at the surface epithelium
(mean score, 0.20). This number was significantly increased in cases with chronic gastritis (mean
score, 1.06) and in those with intestinal metaplasia (mean score, 2.56). Within the intestinal metapla-
sia cases, 44 different foci of intestinal metaplasia were identified. In 39 of these 44 areas, concentra-
tions of apoptotic cells were seen immediately adjacent to the foci of intestinal metaplasia, but not in
the metaplastic epithelium itself.
Conclusions: Apoptosis is uncommon in normal gastric mucosa. Chronic inflammation and intestinal
metaplasia are associated with increased apoptosis, but occur mainly at the mucosal surface and not
in the deeper layers. These findings do not support the concept that apoptosis underlies the loss of gas-
tric glands and leads to atrophy, but the observed concentration of apoptotic epithelial cells adjacent
to foci of intestinal metaplasia could be related to heterogeneity of epithelial damage, causing apop-
tosis, to which intestinal metaplasia is a response.
Colonisation of the human stomach with Helicobacterpylori almost invariably induces chronic active gastritis,a condition that predisposes to the development of gas-
tric mucosal atrophy,1 which is thought to be an important
precursor of gastric adenocarcinoma. So far, the biological
processes involved in the progression from H pylori induced
gastritis to glandular atrophy have not been completely eluci-
dated. One of the proposed mechanisms playing a role in this
process is an increased apoptosis to proliferation ratio. In nor-
mal gastric mucosa, proliferating stem cells are located in the
neck region. New cells migrate either upwards, differentiating
into foveolar epithelial cells, or downwards, differentiating
into glandular cells. After a certain period, both cell types
undergo programmed cell death at the surface epithelium or
in the gland. It has been hypothesised that colonisation with
H pylori leads to a significant increase in the proportion of cells
undergoing apoptosis and thus to a change in the balance
between proliferation and cell death. Indeed, some authors
have reported an increased number of apoptotic cells in H py-
lori colonised gastric mucosa compared with normal
mucosa.2 3 However, these studies were performed by means of
the terminal deoxynucleotidyl transferase mediated dUTP
nick end labelling (TUNEL) assay, which has the disadvantage
that the results are influenced by the type and duration of
fixation.4–7 This might explain some of the previous reports of
very high proportions of apoptotic cells in H pylori colonised
gastric mucosa.3
“It has been hypothesised that colonisation with Helico-
bacter pylori leads to a significant increase in the
proportion of cells undergoing apoptosis and thus to a
change in the balance between proliferation and cell
death”
Recently, new antibodies directed against active caspase
3 and cleaved cytokeratin 18 have become available,8 9
enabling the determination of apoptotic cells with a higher
sensitivity and specificity than is possible using the TUNEL
method. The aim of our present study was to evaluate the
role of apoptosis in the development of gastric mucosal
atrophy and intestinal metaplasia using these new anti-
bodies.
MATERIALS
Using tissue sections from 40 gastric resection specimens,
samples with normal gastric mucosa (n = 5), mild to severe
chronic active gastritis (n = 17), and foci of intestinal
metaplasia (n = 18) localised in a surrounding of chronic
active gastritis were analysed (table 1). Thirty six samples
were corpus mucosa, three were antral mucosa, and one was
from the cardia. In all cases, (partial) gastrectomy had been
performed because of cancer. In addition, 10 samples of gastric
adenocarcinoma and three biopsy specimens with normal
colorectal mucosa were used as positive controls for M30
CytoDeath (antibody directed against cleaved cytokeratin 18)
and active caspase 3 staining.10 Germinal centres of lymphoid
follicles served as positive controls for active caspase 3 and
negative controls for M30 CytoDeath. All specimens were for-
maldehyde fixed and paraffin wax embedded, and had been
collected from the archives of the department of pathology, VU
University Medical Center, Amsterdam, The Netherlands.
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METHODS
Serial sections (4 µm thick) were cut and stained using a
standard three step streptavidin–biotin complex method.
First, slides were dewaxed for 3 × 10 minutes in xylol and
rehydrated in 100%, 96%, and 70% ethanol and water. Endog-
enous peroxidase was blocked for 30 minutes in methanol
with 0.3% H2O2. After rinsing in water, antigen retrieval was
achieved by microwaving for 10 minutes at 360 W in citrate
buffer (10 mmol/litre, pH 6.0). Slides were rinsed in phos-
phate buffered saline (PBS).
For the detection of cleaved cytokeratin 18, slides were
preincubated with normal rabbit serum (Dako, Glostrup,
Denmark; 1/50 dilution) for 10 minutes and then incubated
for 60 minutes with the mouse monoclonal antibody M30
CytoDeath (Roche, Mannheim, Germany; 1/100 dilution).
After rinsing in PBS, slides were incubated with biotin
labelled rabbit antimouse antibody (Dako; 1/500 dilution) for
30 minutes, again rinsed in PBS, and incubated with
streptavidin–biotin complex (Dako; 1/200 dilution) for 60
minutes.
For the detection of active caspase 3, slides were preincu-
bated with normal swine serum (Dako; 1/10 dilution) for 10
minutes and then incubated with the rabbit monoclonal anti-
active caspase 3 antibody (BD PharMingen, San Diego, USA;
1/400 dilution) for 60 minutes. After rinsing in PBS, slides
were incubated with biotin labelled swine antirabbit antibody
(Dako; 1/300 dilution) for 30 minutes. Next, the slides were
incubated in streptavidin–biotin complex (Dako; 1/1000 dilu-
tion) for 30 minutes, rinsed in PBS, followed by incubation
with biotinylated tyramine for 10 minutes, rinsed in PBS
again, and incubated with streptavidin–biotin complex (Dako;
1/200 dilution).
After rinsing in PBS, peroxidase was developed with the
DAB (diaminobenzidine) chromogen for three minutes. After
rinsing in water, slides were counterstained with haematoxy-
lin for 30 seconds.
Staining was evaluated by light microscopy and the number
of positive cells was assessed by two observers (NvG, GA), who
discussed the case until they reached consensus. The samples
were scored on a 0–3 scale, as follows: 0, no positive cells; 1,
single positive cells; 2, small groups of positive cells; and 3,
large areas of adjacent positive cells. Figure 1 shows examples
of these scores.
RESULTS
In all control specimens, a specific staining pattern was seen
for both the M30 CytoDeath and active caspase 3 antibodies.
M30 CytoDeath and anti-active caspase 3 typically produced a
cytoplasmic staining pattern with highest intensity along the
cell membrane. On serial sections, M30 CytoDeath and
anti-active caspase 3 colocalised. When present, lymph
follicles showed high numbers of cells positive for active cas-
pase 3, but not for M30 CytoDeath, which is compatible with
the fact that cytokeratin 18 is only present in epithelial cells
and not in lymphocytes. In gastric adenocarcinoma samples,
morphologically well recognisable apoptotic cells showed
positive staining with both antibodies. In biopsy specimens of
the colon, positive staining was seen in the surface epithelium
of normal colorectal mucosa, as was expected.
First, M30 CytoDeath and anti-active caspase 3 positivity
was scored in five samples with normal gastric mucosa, 17
with chronic active gastritis, and 18 with intestinal meta-
plasia. In normal gastric mucosa, low numbers of immuno-
positive cells for both cleaved cytokeratin 18 and active
caspase 3 were seen (mean score for the number of positive
cells, 0.20; range, 0–1) (fig 2). These cells were almost exclu-
sively seen at the surface epithelium (fig 3A) with a patchy
distribution. No positive cells were seen in the foveola and
glandular layer.
Table 1 Overview of cases included in our study and
mean immunoscores for cleaved cytokeratin 18 in
normal mucosa, chronic gastritis, and intestinal
metaplasia
Type of lesion N (slides/areas)
Mean M30 score
(range)
Normal gastric mucosa 5/5 0.20 (0–1)
Chronic gastritis 17/27 1.06 (0–3)
Intestinal metaplasia 18/44 2.56 (1–3)
M30 score = cleaved cytokeratin 18 score.
Figure 1 Examples of gastric tissue sections stained for M30
CytoDeath immunoscored as (A) 1, (B) 2, and (C) 3.
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In comparison with normal gastric mucosa, significantly
higher numbers of M30 CytoDeath and active caspase 3 scores
were seen in cases with chronic active gastritis (mean score for
the number of positive cells, 1.06; range, 0–3; p < 0.001) and
intestinal metaplasia (mean score for the number of positive
cells, 2.56; range, 1–3; p < 0.001). Positive cells were found
almost exclusively in the foveolar layer and the surface
epithelium. M30 CytoDeath and active caspase 3 positivity in
the glandular layer was rare. In only two samples, a few apop-
totic epithelial cells could be detected in the glandular layer of
the gastric mucosa.
Next, the relation between apoptosis and intestinal
metaplasia was studied in more detail. Within the intestinal
metaplasia cases, 44 different foci of intestinal metaplasia
were identified, and in 39 of these cases increased concentra-
tions of apoptotic cells were seen in the foveolar and surface
epithelium, immediately adjacent to these foci of intestinal
metaplasia (fig 3B,C). Only two of these 39 foci contained
apoptotic cells within the intestinal metaplastic epithelium
itself.
DISCUSSION
Helicobacter pylori induced gastritis is strongly associated with
the development of gastric mucosal atrophy and intestinal
metaplasia,1 conditions that are thought to increase the risk
for the development of gastric adenocarcinoma. It has been
hypothesised that H pylori infection disturbs the balance
between cell proliferation and apoptosis, in particular by
inducing apoptosis. Indeed, increased numbers of apoptotic
cells of up to 16.8% have been reported in H pylori infected
gastric mucosa, compared with 1–3% in normal mucosa.2 3
However, others reported that the number of apoptotic cells in
H pylori gastritis was within normal limits.11–13 These studies
were based on the use of a TUNEL assay, and the discrepancies
between these studies may be explained, at least in part, by the
limited specificity and sensitivity of this method. The TUNEL
assay has been shown to be very sensitive to fixation. Further-
more, pretreatment of the tissue induces general labelling of
normal cells.4 5 14 With the new immunohistochemical
antibodies—M30 CytoDeath, which is directed against cleaved
cytokeratin 18, and anti-active caspase 3,9 directed against a
key enzyme in the final common pathway of apoptosis—it is
now possible to study apoptosis reliably in relation to tissue
morphology in H pylori gastritis.14 Cytokeratin 18 is present in
several types of epithelial cells and is cleaved during apoptosis,
and as such M30 CytoDeath positivity can be regarded as a
functional read out of apoptosis in tissue sections. In our
present study, in non-neoplastic gastric mucosa, both active
Figure 2 Scatter (sunflower) plot showing M30 CytoDeath
immunopositivity scores (0–3) for normal mucosa, chronic gastritis,
and intestinal metaplasia, with each petal of a sunflower
representing one case.
Figure 3 (A) Apoptotic epithelial cells were detected at the gastric
surface mucosa with M30 CytoDeath. (B) Apoptotic cells were found
at the transitional margins between intestinal metaplasia (arrows)
and gastritis with M30 CytoDeath. (C) The same area shown in (B)
but at a higher magnification (×10).
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caspase 3 and M30 CytoDeath microscopically showed very
specific positive staining in the cytoplasm of epithelial cells in
which the nucleus, on haematoxylin and eosin staining, did
not yet show a typical apoptotic phenotype. In addition,
immunopositive staining was found at the surface of both
colorectal and gastric mucosa, where it would be expected
considering the normal physiology of these tissues. Further-
more, M30 CytoDeath and active caspase 3 colocalised in
almost all cases. In lymph follicles in the gastric mucosa, a
subset of lymphocytes showed positivity for active caspase 3,
but not for M30 CytoDeath, as was expected, because cytok-
eratin 18 is not present in lymphocytes. In addition, morpho-
logically recognisable apoptotic cells in tissue sections with
gastric adenocarcinoma also showed clear staining with M30
CytoDeath and anti-active caspase 3. These observations pro-
vide further evidence of the reliability of these antibodies as
histological markers of apoptosis. In theory, H pylori may
induce apoptosis either directly or indirectly via inflamma-
tory factors, such as cytokines, released during H pylori
induced chronic gastritis. This would result in caspase 9
mediated, stress induced apoptosis. Alternatively, the caspase
8 mediated pathway may be activated via induction of a cyto-
toxic T cell response.2 15–20 The fact that in our present study
apoptosis was seen mainly at the surface of the gastric
mucosa favours stress induced apoptosis, rather than T cell
mediated apoptosis. In both cases, a cascade of caspases is
cleaved and thus activated, with caspase 3 as a common final
pathway. Caspase 3 finally cleaves target proteins, such as
structural proteins in the cytoplasm, including cytokeratins,
or proteins involved in homeostasis and repair mechanisms
in the nucleus.8
“If an increased apoptotic rate does play a role in the
development of glandular atrophy, an increased number
of M30 CytoDeath and active caspase 3 positive cells
would be expected in the glandular layer and/or the
neck region of the gastric mucosa”
In a subset of H pylori infected subjects, longterm chronic
gastritis will finally lead to mucosal atrophy; that is, the loss
of specific glandular epithelium. It has been hypothesised
that apoptosis of epithelial cells is the cause of this atrophy.
However, this concept could not unambiguously be confirmed
by our present data. First, the high numbers of apoptotic cells
in the gastric mucosa previously reported were not confirmed
by our findings.2 3 Second, in our present study, apoptotic cells
were almost always located in the surface epithelium of the
gastric mucosa. If an increased apoptotic rate does play a role
in the development of glandular atrophy, an increased
number of M30 CytoDeath and active caspase 3 positive cells
would be expected in the glandular layer and/or the neck
region of the gastric mucosa. Similar to uninfected surface
epithelium, apoptotic cells were found only rarely in the
glandular layer of H pylori colonised gastric mucosa, suggest-
ing that H pylori colonisation and the resulting gastritis do
not result in increased apoptosis in the glandular layer and
the neck region.
A remarkable finding was the observation that concentra-
tions of immunopositive cells occurred in the foveolar epithe-
lium immediately adjacent to foci of intestinal metaplasia,
whereas in the metaplastic epithelium itself, apoptotic cells
were seen in only two foci. Most of the 44 foci of intestinal
metaplasia that we studied did not show apoptotic cells,
whereas the adjacent epithelium did contain these cells (fig
3B,C). This distribution pattern has been described previously
with the TUNEL assay,21 and a similar staining pattern was
described for Fas (CD95) expression in Barrett’s metaplasia.22
Intestinal trefoil factors (TFF1, TFF2, and TFF3), which may
be involved in the development of intestinal metaplasia,23 are
also thought to prevent apoptosis at sites of mucosal injury
(for example, peptic ulcer disease, inflammatory bowel
disease).24 25 Therefore, a possible mechanism could be that
H pylori induces an increased apoptotic rate in the gastric sur-
face epithelium, which is a major threat for the integrity of the
gastric mucosa. In response to this, the upregulation of trefoil
factors would cause both a reduction of apoptosis of epithelial
cells and a change in epithelial differentiation towards intesti-
nal metaplasia. As a result, the gastric mucosal epithelium
would be better able to resist the environmental pressure
leading to apoptosis and its integrity would be better
preserved. However, in the long run, this metaplasia would
result in an increased risk of cancer.26 27 Because intestinal
metaplasia is patchy and apoptosis appears to concentrate
around these patches, it seems that this apoptotic pressure is
heterogeneous throughout the gastric epithelium. However,
our present data are also consistent with a mechanism in
which intestinal metaplasia is not preceded by mucosal
atrophy, as is proposed by Correa et al, but occurs directly in
response to the mucosal damage that induces programmed
cell death.28 29
In conclusion, apoptosis is uncommon in normal gastric
mucosa. Chronic inflammation and intestinal metaplasia are
associated with increased apoptosis at the mucosal surface,
but not in the deeper layers. These findings do not support a
role for apoptosis in the development of atrophy. The observed
concentration of apoptotic epithelial cells adjacent to foci of
intestinal metaplasia could be related to heterogeneously dis-
tributed epithelial damage, to which intestinal metaplasia is a
response.
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Testing for dsDNA antibodies is superior by Farr
Across sectional study in a routine setting has found that Farr radioimmunoassay is moresensitive than a new automated fluorescence immunoassay for diagnosing systemiclupus erythematosus (SLE).
Farr immunoassay performed better at identifying antibodies to dsDNA in serum samples
of patients with suspected SLE or lupus like disease (LLD). At specificities of 95% and 99% the
corresponding sensitivities were 72% and 56%, respectively, but in the automated fluorescence
immunoassay (ELIA dsDNA test) were only 44% and 17%, respectively. These values were
obtained from receiver operating curves (ROC) for each test calculated from samples from
SLE and non-SLE, non-LLD patients. Of all 440 patients, 115 (36%) were grouped as non-SLE,
non-LLD; 77 (18%) LLD; and 248 (56%) as SLE according to American College of Rheumatol-
ogy (ACR) criteria.
The samples were sent for routine hospital testing for dsDNA antibodies. Each sample was
tested by the two methods according to the manufacturers’ instructions. A researcher who
was blinded to the assay results grouped patients by the number of ACR criteria they
displayed (>4, SLE; 1–3, LLD; and zero or antinuclear antibody positive, non-SLE, non-LLD).
Farr immunoassay is commonly used to detect dsDNA antibodies—one of the four ACR
criteria for diagnosing SLE. It is very specific and predictive for SLE. The ELIA dsDNA test has
recently been claimed to be comparable in performance and cost, but quicker and more con-
venient. However, the comparisons relied on less appropriate control samples from a mixture
of sources and less “realistic” (non-routine) test conditions.
m Annals of the Rheumatic Diseases 2002;61:1099–1102.
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